This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tiago Ferreira - Innovator in Cancer Research
Introduction
Tiago Ferreira is an accomplished inventor based in Heidelberg, Germany. He is affiliated with the Deutsches Krebsforschungszentrum - Stiftung Des Öffentlichen Rechts / Universität Heidelberg. His work primarily focuses on cancer research, where he aims to develop innovative methods for predicting treatment responses in patients.
Latest Patent Applications
Tiago Ferreira has submitted a patent application titled "Method for Predicting the Clinical Response of Oncolytic Parvovirus H1 (H-1PV) Treatment in a Patient Suspected of Suffering from Cancer by Measuring the Expression Levels of Laminins and/or Galectins as Biomarkers in a Patient's Sample." This invention concerns the use of laminins and/or galectins as biomarkers for predicting the outcome of treatment with oncolytic parvovirus H1 in cancer patients.
Conclusion
Tiago Ferreira's contributions to cancer research through his innovative patent applications highlight his commitment to improving patient outcomes. His work exemplifies the importance of research in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile